A Real-World, Multicenter, 6-Month Prospective Study in Gree

A Real-World, Multicenter, 6-Month Prospective Study in Greece of the Effectiveness and Safety of Ranibizumab in Patients with Age-Related Macular Degeneration Who Have Inadequately Responded to Aflibercept: The “ELEVATE” Study

Related Keywords

Helsinki , Eteläuomen Läi , Finland , Greece , , Multivariable Linear Regression Analysis Of The Association , Good Pharmacoepidemiology Practice , International Society , Institutional Review Boards , Last Observation Carried Forward , Disease Characteristics , Anatomical Measures , One Month , Three Months Post Ranibizumab Treatment Onset , Study Eyes , Available Paired , Six Months Post Ranibizumab Treatment Onset , Treatment Characteristics , Linear Regression Analysis , Between Baseline , Various Patient ,